Gastrointestinal and Hematologic Disorders Flashcards
Myelodysplastic Syndromes
- Definition: A group of hematopoietic disorders characterized by cellular dysplasia and pancytopenia (↓ RBC, WBC, and platelets).
- Synonyms: Dysmyelopoietic syndrome, hematopoietic dysplasia, pre-leukemia, refractory anemia.
- Classifications: Refractory anemia, chronic myelomonocytic leukemia, refractory anemia with excess blasts in transformation.
Epidemiology
- Predominant Age: Elderly, >65 years.
- Children: Uncommon.
- Progression: May progress to acute myeloid leukemia (AML).
- Predominant Sex: Male = Female.
- Incidence: 1-2/100,000 per year.
Risk Factors
- Exposure to benzene and gasoline.
- Smoking.
- Treatment with alkylating agents or radiotherapy.
- Genetic factors: G6PD mutation, RAS oncogene mutation.
- Clonal neoplasms by cytogenetic abnormalities.
- Unknown etiology.
Pathophysiology
- Clonal hematopoiesis leading to expansion of abnormal clones and apoptosis.
- Genetic mutations leading to increased apoptosis in the early stages.
- Ineffective hematopoiesis causing anemia, neutropenia, and thrombocytopenia.
Signs & Symptoms
- Anemia: Fatigue, pale skin, shortness of breath, lightheadedness, angina.
- Leukopenia: Fever, increased risk of infection.
- Thrombocytopenia: Easy bruising, petechiae, epistaxis, purpura.
- **Skin infiltrates.
- Splenomegaly: Uncommon, but may occur in chronic myelomonocytic leukemia (CMML).
Diagnosis
- Cytogenetic tests for clonal chromosomal abnormalities.
- Rule out other causes: nutritional deficiencies, toxic exposures, autoimmune disorders.
- Granulocyte function test.
- Platelet function test.
- Marrow colony assays.
- Immunophenotyping.
Laboratory Findings
- Increased MCV (macrocytic anemia).
- Reticulocyte count (may be elevated or normal).
- Bone marrow failure.
- Anemia: Macrocytic (MCV > 100), poikilocytosis, anisocytosis, reticulocytosis.
- Granulocytopenia: Hypogranular or agranular neutrophils.
- Thrombocytopenia: Giant platelets or hypogranular platelets.
- HbF (fetal hemoglobin): Should be ruled out as a cause; Thalassemia; HbF fetus stage.
- Coombs test: To rule out hemolytic anemia.
- Imaging: Liver/spleen scan for splenomegaly or lymphadenopathy.
- Bone marrow aspiration, biopsy: Hypercellular with increased blasts.
- Peripheral blood smear.
Differential Diagnosis
- Myeloproliferative disorders (no cytopenia).
- AML or erythroleukemia (acute).
- Chronic myeloproliferative disorders (adequate maturation).
- Polycythemia Vera (too much blood production, Hb 17-18).
- Myeloid metaplasia with myelofibrosis.
- Malignant lymphoma.
- Metastatic carcinoma.
Treatment
- Immunizations: Pneumococcal pneumonia, influenza, Hep B.
- RBC transfusions.
- Platelet transfusions.
- Early antibiotic use.
- Diet: Avoid alcohol and iron intake.
- Medications:
- 1st line: Azacytidine, Decitabine, Lenalidomide.
- Chemotherapy.
- Bone marrow transplant.
- 2nd line: Low dose cytarabine, interferon, cyclosporine, granulocyte colony-stimulating factor.
Prognosis
- Refractory anemia (survival: 5 years or longer).
- Others: 1 year (death due to AML or infection/bleeding).
Complications
- Infection.
- Bleeding.
- Complications of anemia and transfusion.
- Citrate toxicity -> Urolithiasis (from citrate in blood bags).
Acute Myeloid Leukemia (AML)
- Synonyms: Acute myelogenous leukemia, acute granulocytic leukemia.
- Definition: Cancer of the blood and bone marrow affecting myeloid cells (↓ RBC, WBC, platelets) with rapid growth of abnormal WBCs.
Epidemiology
- Adults > 45 years.
- 1% of all cancer types.
Risk Factors
- Age (more common in older adults).
- Sex: Male > Female.
- Smoking (leads to lung cancer).
- Exposure to chemicals: Benzene, oil refinery, shoe manufacturing, gasoline.
- Exposure to formaldehyde.
- Chemotherapy drugs: Alkylating drugs (Cyclophosphamide, Procarbazine, Busulfan).
- High dose radiation exposure.
- MDS.
- Genetic: Fanconi anemia, Bloom syndrome, Neurofibromatosis type I.
- Family history.
Etiology
- Abnormality of chromosome aging.
- Genetic mutations.
- Changes in DNA affecting control functions.
- Decrease in tumor suppressor genes.
Diagnosis
- Screening tests for early detection are not helpful in AML.
- Blasts in AML.
Signs & Symptoms
- Non-specific: Weight loss, fatigue, fever, night sweats, loss of appetite.
- Leukopenia: Fever, infection.
- Thrombocytopenia: Bruises, excess bleeding, nosebleed, bleed gums, heavy periods.
- Confusion.
- Splenomegaly.
- Hepatomegaly.
- Bone marrow infiltration.
- Enlarged lymph nodes.
- Swelling, pain, bleeding gums.
Subtypes
- Goal: for easier treatment
- M0-M5: Immature forms of WBC- monocyte
- M6: Very immature forms of RBC- erythroblast
- M7: Immature forms of platelet making.
Prognosis
- Depends on factors, subtypes.
Treatment
- Refers to Oncology department.
- Chemotherapy.
- Radiotherapy.
Differential Diagnosis MDS vs AML
- Blasts <20% vs Blasts ≥20%.
Chronic Myeloid Leukemia (CML)
- Definition: Cancer of WBCs characterized by increased unregulated growth of myeloid cells in bone marrow and accumulation in blood.
- Chronic > 3 months without proper treatment.
- Differentiate of MDS, AML, CML.
Epidemiology
- Male > Female.
- Age: Any age, mostly 60 years.
- Adults (mainly), children (rarely).
Risk Factors
- Expose skin to strong sunlight.
- Smoking.
- High dose radiation exposure (atomic bomb or nuclear).
- Aging.
- Sex: Male > female.
- G6PD deficiency.
Etiology
- Chromosome 9 and 22 swapped (Philadelphia chromosome).
- Defected chromosome (oncogene): BCR-ABL gene.
- Produce protein cause CML grow & divide out of control.
Signs & Symptoms
- Weakness.
- Fatigue.
- Night sweats.
- Weight loss.
- Fever.
- Risk of infection.
- Bone pain, joint pain (caused by leukemia spreading from marrow cavity to bone or joint).
Diagnosis
- Screening CBC: abnormity of RBC, WBC, platelets.
- Tumor marker (should be next if CBC level is normal/abnormal).
- Lab test: Increased WBC, immature myeloblasts, increased platelets.
- Bone marrow biopsy: Hypercellularity with myeloid hyperplasia.
- Philadelphia chromosome presence.
Phases of CML
- Chronic phase: Blasts <10%; more responsive to tyrosine kinase inhibitors.
- Accelerated phase: Basophilia, blasts 15%; not respond well to treatment.
- Blast phase: Large cluster of blast in bone marrow, Blasts ≥20%; like AML symptoms, refractory.
Prognosis
Liver Cirrhosis
- Definition: Chronic liver disease leading to inflammation, necrosis, fibrosis, and stellate activation - end result liver failure or cancer
- Definition Chronic liver disease (alcohol abuse)Chronic Liver disease (non-alcohol +obesity) -> liver steatosis (fatty liver disease) -> fat + liver secrete enzyme irritate hepatocyte -> prolong -> liver steatosis.
Epidemiology
- Predominant age: 40-50 /peak incidence
- Predominant sex: Male
- Alcohol abuse -15th cause of death at 45-54 yrs
- 12 cause of death in US adults
Genetics:
- hemochromatosis
- wilson disease
- a1-Antitrypsin deficiency in adults
Etiology & Pathophysiology
- Toxins -> hepatocyte injury -> secrete paracine factor to become -> activate & change stellate -> transforming growth factor-B-1
- Virus -> stellated -> lose vit. A & start secrete TGF-B1
- Produce collagen - extracellular matrix -> fibrosis & scaring compress central vein & sinusoid but normally healthy liver state stellated function wound healing on liver injury cirrhosisbile stasis (gallstone, duct obstruct bile reflux into liver-
- Metabolic disorder (PTG + poor liver inflammation -> liver steatosis)
- Autoimmune disease
Risk Factors
- Alcohol abuse
- History of viral hepatitis
- Family history of primary liver cancer
- Signs & Symptoms
- Asymptomatic early stage (liver compensate I still get - work done)
- Non-specific : weight loss , weakness, fatigue, anorexia
- Late stage (liver decompensate) -> extensive fibrosis (malfunction
Clinical Manifestations of decompensated liver state
- Skin changes spider angiomata - superficial vein
- Xanthoma(cholesterolmotiveheimer liver malfunction
- hyperpigmentation
- jaundice
- Caput medusa Overflow of fluid in belly (joy belly & umbilical cord vory/o)
- Leg edema
- Hepatomegaly, splenomegaly , cirrhotic liver